John Armitage's Egerton Capital has liquidated its entire position in Carpenter Technology Corp. (CRS), according to a recent SEC filing. The disclosure, which reflects holdings as of June 30, 2026, shows the sale of all 1.33 million shares, previously valued at approximately $524.58 million. This holding had accounted for a significant 5.82% of Egerton's reported portfolio.
As a major global producer of specialty alloys for the aerospace, defense, and medical industries, Carpenter Technology is a key industrial player. Investors should note that 13F filings are submitted with a delay, so this trade occurred sometime in the second quarter of 2026. Egerton Capital, known for its fundamental, research-driven investment approach, has not publicly commented on the reasons for this substantial exit.